The Fanconi anaemia/BRCA pathway

D'Andrea, Alan D., Grompe, Markus·2003·Nature Reviews Cancer
DOI 10.1038/nrc970

Cited by (823)

Items 701–800 of 823

  1. Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect
    Ceren Damla Durmaz, Fatma Gümrük, Tiraje Tülin Celkan, Sule Unal, Arda Çetinkaya · 2024 · American Journal of Medical Genetics Part A
  2. Oncogenic properties of wild-type DNA repair gene FANCA in breast cancer
    Liang Luo, F. Yuan, A. Palovcak, Fang Li, Qingqi Yuan, Daniel Calkins, Zoe Manalo, Yan Li, Da-Zhi Wang, Mike Zhou et al. · 2025 · Cell Reports
  3. Genetische Grundlagen der Kanzerogenese
    Claus Rainer Bartram · 2009 · Springer eBooks
  4. Dna Damage and Repair
    Ester M. Hammond, Isabel M. Pires, Amato J. Giaccia · 2010 · Elsevier eBooks
  5. Clinical Features of Fanconi Anaemia
    Alexander Malcolm R. Taylor · 2007 · Springer eBooks
  6. Preventing hereditary cancers caused by opportunistic carcinogens
    Bernard Friedenson · 2011 · Nature Precedings
  7. DUBing down a tumour suppressor
    Ashok R. Venkitaraman · 2005 · Nature Cell Biology
  8. Fanconi anemia: now we are 11
    Eric Nisbet‐Brown · 2004 · Blood
  9. DNA Interstrand Crosslink Repair
    Wolfram Siede · 2014 · Wiley eBooks
  10. Inherited mutations impair responses to environmental carcinogens: Cancer prevention in mutation carriers
    Bernard Friedenson · 2011 · Nature Precedings
  11. Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia
    Zafar Iqbal, Muhammad M. Absar, Tanveer Akhtar, Aamer Aleem, Abid Jameel, Sulman Basit, Anhar A. Ullah, Sibtain Afzal, Khushnooda Ramzan, Mahmood Rasool et al. · 2024 · Preprints.org
  12. In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi’s Anemia
    Craig Dorrell, Sebastian Restrepo Cruz, Allison MacMillan, A. Mack Peters, Barbara Ann Burtness, Markus Grompe · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Colorectal cancer and defects in the mismatch repair and base excision repair systems
    Susa Enholm · 2004 · Työväentutkimus Vuosikirja
  14. The Impact of Chemoprevention on Treatment Regimens for Non- Muscle Invasive Bladder Cancer
    Jennifer A. Higgins · 2011 · Figshare
  15. Análise do complexo gênico FANCD2/FANCI em mulheres brasileiras com câncer de mama herediitário
    Lucila Gobby Amstalden · 2011
  16. Saccharomyces cerevisiae DNA helicases Mph1, Srs2 and Sgs1 collaborate for the reinitiation of stalled or collapsed replication forks
    Evandro Rocco Panico · 2006
  17. Myelodysplasia and Myeloid Proliferations
    Zeba N. Singh, Margaret L. Gulley · 2012 · Humana Press eBooks
  18. The FANC Genome Surveillance Complex
    Takayuki Yamashita · 2007 · Springer eBooks
  19. The Fanconi anemia-BRCA Pathway and Cancer
    Toshiyasu Taniguchi · 2009 · Springer eBooks
  20. HPV Virology: Cellular Targets of HPV Oncogenes and Transformation
    Eric A. Smith, Marie C Matrka, Susanne I. Wells · 2015 · Springer eBooks
  21. Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer
    Maria I. Harrell · 2015 · ScholarWorks (Walden University)
  22. Uncovering Orthologous Genes of the Ciona Intestinalis Fanconi Anemia Pathway
    Edward C. Stanley · 2015
  23. Elevated Levels of Somatic Mutation as a Biomarker of Environmental Effects Contributing to Breast Carcinogenesis
    Stephen G. Grant · 2002
  24. Xenopus laevis as a model system for evaluating the function of fanconi anemia proteins
    Stacie Stone · 2008 · Pure Amsterdam UMC
  25. Inflammatory ROS in Fanconi Anemia Hematopoiesis and Leukemogenesis
    Wei Du · 2012 · InTech eBooks
  26. Identification of putative interactors of Fanconi anaemia proteins by yeast to hybrid system: characterization of two novel genes highly expressed during spermatogenesis
    Fabio Morgese · 2009 · OpenstarTs (Univeristy of Trieste https://www.units.it/)
  27. CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
    Marijke Wasielewski · 2009 · RePub (Erasmus University Rotterdam)
  28. Untersuchungen zur Wirksamkeit von Dacarbazin und Temozolomid bei der Behandlung des kutanen Melanoms in Assoziation mit DNA-Reparatur
    Lars Boeckmann · 2010 · eDiss (Georg-August-Universität Göttingen)
  29. Signaling functions of fanconi anemia proteins
    Scott M. Vanderwerf · 2008 · OHSU Digital Commons
  30. Epigenetic Drivers of Genetic Alterations in Cancer
    Hiromu Suzuki · 2012 · Wiley eBooks
  31. Assessing the genetic integrity of tumours by microsatellite loci of forensic interest
    Hanna Vauhkonen · 2005 · Työväentutkimus Vuosikirja
  32. The Fanconi anemia DNA maintenance pathway: focus on the FANCE and FANCF proteins
    France Léveillé · 2006 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
  33. The FANC B, E, F and G Genes and Their Products
    Filippo Rosselli · 2007 · Springer eBooks
  34. Does cGMP mediate platelet inhibition or stimulation?
    Wolfgang Siess · 2004 · Blood
  35. New EMBO Member’s Review Ubiquitylation and cell signaling
    Kaisa Haglund, Ivan Đikić · 2014
  36. BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
    Panagiotis A. Konstantinopoulos, Ursula A. Matulonis · 2013 · Clinical Investigation
  37. Genomic signatures of BRCA1 but not BRCA2 associated high‐grade serous carcinoma resemble basal‐like breast cancer
    JV Patankar · 2013 · Clinical Genetics
  38. Mecanismos de indução de apoptose pela presença de danos ao DNA: um estudo sobre o papel de p53 na resistência de células de glioma a agentes quimioterápicos.
    Luís F.Z. Batista · 2008 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  39. p53 and DNA damage checkpoint responses in the human prostate
    Taija af Hällström · 2007
  40. Diagnóstico laboratorial da Anemia de Fanconi: análise da via de interação das proteínas AF/BRCA por meio da detecção da proteína FANCD2 e de sua forma monoubiquitinada pelo Método de Western Blot/
    Daniela Pilonetto · 2007 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  41. Correspondence re: M. S. van der Heijden et al., Fanconi Anemia Gene Mutations in Young-onset Pancreatic Cancer. Cancer Res.,63: 2585–2588, 2003.
    Quinten Waisfisz, Gerard Pals, Hans Joenje, Michiel S. van der Heijden, Ralph H. Hruban, Scott E. Kern · 2003 · Cancer Research
  42. A novel myeloma cell line identified for multidrug resistant study
    Hui Xiao, Qi Xiao, Kejian Zhang, Xuelan Zuo · 2009 · The Chinese-German Journal of Clinical Oncology
  43. Der Zusammenhang von strahleninduziertem Zelltod (Apoptose) und dem protektiven G2-M-Arrest in menschlichen Zellen
    Dornreiter, Irene · 2015 · PUBLISSO (German National Library of Medicine)
  44. IN THE SPOTLIGHT BRCA1: A Missing Link in the Fanconi Anemia/BRCA Pathway
    Alan D. D’Andrea · 2013
  45. THE DEFECTS IN THE FANCONI ANEMIA PATHWAY IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Erin M. O’Leary · 2005
  46. 2003: A Powerful Year of Confluence
    David P. Beck · 2003
  47. Processing of cisplatin interstrand crosslinks (ICLs) by DNA repair proteins
    Venkata Srinivas Mohan Nimai Dangeti · 2012 · OhioLink ETD Center (Ohio Library and Information Network)
  48. Role of Smad4 loss in head and neck squamous cell carcinoma
    Sophia Bornstein · 2008
  49. Development and Validation of an Assay for the Characterization of the DNA Damage Response to Damage Caused by Superfund Chemicals
    John R. Ridpath · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  50. Genetic Pathways in Pancreatic Tumorigenesis
    Eike Gallmeier, Scott E. Kern · 2008 · Springer eBooks
  51. DNA damage response activated by anti-cancer agent, irofulven
    Timothy D. Wiltshire · 2007
  52. SYT -SSX1 regulates PIASy activity to cause the overexpression of NCOA3 in synovial sarcoma
    Juanita Perera · 2009 · UR Research (University of Rochester)
  53. Periimplantitis
    O. Seitz, Jan-Friedrich Dehner, Christoph Schürmann, Constantin Alexander Landes, S. Frank, Markus Schlee, Robert Sader · 2011 · Der MKG-Chirurg
  54. Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary
    Katarzyna Maria Terlikowska, Anna Maria Witkowska, Małgorzata Elżbieta Zujko, Bożena Dobrzycka, Slawomir Jerzy Terlikowski · 2014
  55. Biomarkers for PARP Inhibitors
    Charles Dearman, Ricky A. Sharma, Nicola J. Curtin · 2015 · Cancer drug discovery and develogment/Cancer drug discovery and development
  56. Bone Marrow Aplasia
    Faramarz Naeim, P. Nagesh Rao, Wayne W. Grody · 2008 · Elsevier eBooks
  57. DNA repair inhibition in anti-cancer therapeutics
    Brian Michael Alexander, Alan D. D’Andrea · 2013 · Cambridge University Press eBooks
  58. Genetics and Molecular Biology of Pancreatic and Biliary Cancers
    Anirban Maitra, Charles J. Yeo · 2007 · Elsevier eBooks
  59. [Association between clinical outcome and gene mutation in children with Fanconi anemia].
    Lixian Chang, Ren Ruanruan, Wenyu Yang, Jiayuan Zhang, Yang Wan, Tian‐Feng Liu, Li Zhang, Xiaojuan Chen, Shuai Zhu, Min Ruan et al. · 2016 · PubMed Central
  60. Estudi de l'evolució i el tractament del càncer des d'una perspectiva de la biologia de sistemes
    Jordi Serra-Musach · 2016
  61. Genomic Profiling of Familial Early-Age of Onset Breast Cancer
    Andrew J. Seto · 2015 · TSpace (University of Toronto)
  62. Pancreatic cancer and premalignant tumors
    Jonathan Robert Brody, David W. Rittenhouse, Agnieszka Katarzyna Witkiewicz, Charles J. Yeo · 2012 · Elsevier eBooks
  63. Death Shapes Life: Characterizing the Role of p63 and p73 During Neural Development and Aging
    Sagar Dugani · 2011 · TSpace (University of Toronto)
  64. THE MULTIFACETED ROLE OF EXONUCLEASE 1 IN DNA REPAIR AND ADULT STEM CELL POPULATIONS
    Amar B. Desai · 2014 · OhioLink ETD Center (Ohio Library and Information Network)
  65. Hypoxia Suppresses DNA Repair: Implications for Cancer Progression and Treatment
    Norman Hok Ling Chan · 2011 · TSpace (University of Toronto)
  66. Checkpoint Mediators: Relaying Signals from DNA Strand Breaks Dispatch
    Christine E. Canman · 2003
  67. The Effect of Target-Specific Biomolecules in Breast Cancer
    Mohannad M. Garoub · 2017
  68. X marks the spot
    Jenny Bangham · 2004 · Nature reviews. Cancer
  69. Molecular pathology of pancreatic cancer and premalignant tumors
    Jaclyn Frances Hechtman, Christine A. Iacobuzio–Donahue · 2017 · Elsevier eBooks
  70. Structure and function of the human RecQ DNA helicases
    Patrick L. Garcia · 2005 · Zurich Open Repository and Archive (University of Zurich)
  71. DmBLM’s Functions in DNA Repair and Recombination
    Sabrina L. Andersen · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  72. Ubiquitin Signaling and Cancer Pathogenesis
    Kaisa Haglund, Ivan Đikić · 2007 · Wiley eBooks
  73. Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise
    Lorena Alves Teixeira · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  74. Salinomycin as a potential chemotherapeutic compound in cisplatin-resistant ovarian cancer: effects and mechanisms
    Xiao Yan Zhong, Anton G. Rolink, Raija L.P. Lindberg, Jörg Schibler · 2013
  75. How Fanconi Anemia and Breast Cancer are connected
    Alex Lyakhovich, Jordi Surrallés · 2007
  76. Aplastische Anämien
    Charlotte M. Niemeyer, Irith Baumann, Monika Führer · 2005 · Springer eBooks
  77. Tumor Suppressor Genes
    Bernard E. Weissman · 2005 · CRC Press eBooks
  78. Managing DNA Strand Breaks in Eukaryotic Cells
    Errol C. Friedberg, Graham Charles Walker, Wolfram Siede, Richard Dean Wood, Roger Alan Schultz, Tom Ellenberger · 2014 · ASM Press eBooks
  79. Faculty Opinions recommendation of MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.
    Patrick Gaudray · 2008 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  80. The role of genomics in investigating ultrasound identified fetal structural anomalies
    Mark David Kilby · 2020
  81. Cancer
    2006 · Springer eBooks
  82. DNA Interstrand Crosslink Repair
    Wolfram Siede · 2009 · Wiley eBooks
  83. The Molecular Pathology of Precursor Lesions of Pancreatic Cancer
    Aatur Dilip Singhi, Anirban Maitra · 2017 · Springer eBooks
  84. Fanconi Anemia
    Richa Saxena, Mampi Debnath, Sudha Chamoli · 2018
  85. Panzytopenien
    Monika Führer, C Bender-Götze · 2008 · Springer eBooks
  86. Panzytopenien
    Monika Führer, C Bender-Götze · 2014 · Springer eBooks
  87. Double‐Strand Break Repair
    Albert Pastink, Małgorzata Z. Zdzienicka · 2005 · Springer eBooks
  88. Case 87
    2015
  89. Faculty Opinions recommendation of POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells.
    Errol C. Friedberg · 2003 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  90. Faculty Opinions recommendation of Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication.
    Roland Kanaar · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  91. Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors
    Miguel Angel Villalona-Calero, John Paul Diaz, Wenrui Duan, Zuanel Diaz, Eric D. Schroeder, Santiago Aparo, Troy Antony Gatcliffe, Federico Albrecht, Siddhartha A. Venkatappa, Victor Guardiola et al. · 2022 · Biomarker Research
  92. Data from DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
    Brian Michael Alexander, Kam M. Sprott, D. Allan Farrow, XiaoZhe Wang, Alan D. D’Andrea, Stuart J. Schnitt, Laura C. Collins, David T. Weaver, Judy Ellen Garber · 2023
  93. Data from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers
    Timothy Richard Rebbeck, Nandita Mitra, Susan M. Domchek, Fei Wan, Shannon Chuai, Tara M. Friebel, Saarene Panossian, Amanda B. Spurdle, Georgia Chenevix‐Trench, Christian Fridolin Singer et al. · 2023
  94. Data from DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
    Brian Michael Alexander, Kam M. Sprott, D. Allan Farrow, XiaoZhe Wang, Alan D. D’Andrea, Stuart J. Schnitt, Laura C. Collins, David T. Weaver, Judy Ellen Garber · 2023
  95. Data from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations
    Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, Heather Hondow, Thomas Mikeska, Alexander Dobrovic, Anna DeFazio, Gordon K. Smyth, Douglas A. Levine, Gillian Mitchell et al. · 2023
  96. Identifying Novel Candidate Biomarkers of Early Epithelial Ovarian Cancer
    Sarah Sczelecki · 2023
  97. Endocrine and Genetic Bases of Hormone‐Related Cancers
    Leslie Bernstein, Xia Pu, Jian Hong Gu · 2017 · Wiley eBooks
  98. Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patients
    Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar, Masood A. Shammas, Sarah AlMukhaylid, Amer Mahmood, Zafar Iqbal · 2023 · medRxiv
  99. Inherited Bone Marrow Failure Syndrome–Fanconi Anemia
    Arun K. Das Gupta · 2024 · Springer eBooks
  100. Diagnosing Fanconi Anemia: A Rare Case Report From Rural India
    Aashita Malik · 2024 · Cureus